DE3028927C2 - Azoverbindungen enthaltendes pharmazeutisches Mittel - Google Patents

Azoverbindungen enthaltendes pharmazeutisches Mittel

Info

Publication number
DE3028927C2
DE3028927C2 DE3028927A DE3028927A DE3028927C2 DE 3028927 C2 DE3028927 C2 DE 3028927C2 DE 3028927 A DE3028927 A DE 3028927A DE 3028927 A DE3028927 A DE 3028927A DE 3028927 C2 DE3028927 C2 DE 3028927C2
Authority
DE
Germany
Prior art keywords
connection
compound
test
compounds
azo compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE3028927A
Other languages
German (de)
English (en)
Other versions
DE3028927A1 (de
Inventor
Hiroshi Yokohama Kanagawa Kosuzume
Ei Tokio / Tokyo Mochida
Haruo Funabashi Chiba Onishi
Yasuo Kawaguchi Saitama Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Seiyaku Kk Tokio / Tokyo Jp
Original Assignee
Mochida Seiyaku Kk Tokio / Tokyo Jp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Seiyaku Kk Tokio / Tokyo Jp filed Critical Mochida Seiyaku Kk Tokio / Tokyo Jp
Publication of DE3028927A1 publication Critical patent/DE3028927A1/de
Application granted granted Critical
Publication of DE3028927C2 publication Critical patent/DE3028927C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B29/00—Monoazo dyes prepared by diazotising and coupling
    • C09B29/34—Monoazo dyes prepared by diazotising and coupling from other coupling components
    • C09B29/36—Monoazo dyes prepared by diazotising and coupling from other coupling components from heterocyclic compounds
    • C09B29/3604—Monoazo dyes prepared by diazotising and coupling from other coupling components from heterocyclic compounds containing only a nitrogen as heteroatom
    • C09B29/3647—Monoazo dyes prepared by diazotising and coupling from other coupling components from heterocyclic compounds containing only a nitrogen as heteroatom containing a five-membered ring with two nitrogen atoms as heteroatoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE3028927A 1979-07-30 1980-07-30 Azoverbindungen enthaltendes pharmazeutisches Mittel Expired DE3028927C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP54097059A JPS6056123B2 (ja) 1979-07-30 1979-07-30 浮腫・低血圧・心不全および粘膜充血治療用剤

Publications (2)

Publication Number Publication Date
DE3028927A1 DE3028927A1 (de) 1981-02-26
DE3028927C2 true DE3028927C2 (de) 1984-10-31

Family

ID=14182075

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3028927A Expired DE3028927C2 (de) 1979-07-30 1980-07-30 Azoverbindungen enthaltendes pharmazeutisches Mittel

Country Status (5)

Country Link
US (2) US4315003A (enExample)
JP (1) JPS6056123B2 (enExample)
DE (1) DE3028927C2 (enExample)
FR (1) FR2462161A1 (enExample)
GB (1) GB2057874B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3133886A1 (de) * 1981-08-27 1983-03-17 Bayer Ag, 5090 Leverkusen 2-arylazo-2-imidazoline, acylderivate derselben, verfahren zu ihrer herstellung und die verwendung zur bekaempfung von ekto- und/oder endoparasiten
GB0114008D0 (en) * 2001-06-08 2001-08-01 Perry Robert E New therapautic use
EP1651074A4 (en) * 2003-07-22 2008-07-23 Esther C Fuhrman MAGNETIC JEWELERY CLASP WITH A SAFETY ATTACHMENT
JP6607676B2 (ja) * 2015-01-28 2019-11-20 花王株式会社 Ｔｒｐｖ４活性化剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3102879A (en) * 1958-09-30 1963-09-03 Basf Ag Production of cationic dyestuffs
US3216995A (en) * 1959-06-22 1965-11-09 Basf Ag Method for the production of cationic dyestuffs
US3173907A (en) * 1959-11-27 1965-03-16 American Cyanamid Co Quaternized n-alkylated arylazoimidazoles
BE642347A (enExample) * 1963-04-20
GB1084211A (enExample) * 1963-11-23
DE1544480A1 (de) * 1964-03-26 1970-03-19 Bayer Ag Metallhaltige Monoazofarbstoffe und Verfahren zu ihrer Herstellung
US3981885A (en) * 1971-06-15 1976-09-21 Bayer Aktiengesellschaft 2-Alkyl-phenylhydrazonomidazolenines
US4067973A (en) * 1976-12-27 1978-01-10 The Dow Chemical Company 2-((2-chlorophenyl)azo)imidazoles and their use as an anthelmintic
US4079130A (en) * 1976-12-27 1978-03-14 The Dow Chemical Company Antidepressant phenylazoimidazoles
DE2837953A1 (de) * 1978-08-31 1980-03-13 Bayer Ag Kationische farbstoffe

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS-ERMITTELT

Also Published As

Publication number Publication date
DE3028927A1 (de) 1981-02-26
FR2462161B1 (enExample) 1983-06-24
GB2057874B (en) 1983-11-16
GB2057874A (en) 1981-04-08
JPS6056123B2 (ja) 1985-12-09
US4507237A (en) 1985-03-26
JPS5620516A (en) 1981-02-26
US4315003A (en) 1982-02-09
FR2462161A1 (fr) 1981-02-13

Similar Documents

Publication Publication Date Title
DE69427591T2 (de) 7-(2-imidazolinylamino)quinolin-verbindungen als alpha-2 adrenorezeptor-agonisten
DE1795792A1 (de) Die serumlipoidkonzentration vermindernde arzneimittel
EP0193056A1 (de) Kombination von Flupirtin und anticholinergisch wirkenden Spasmolytika
DE69424183T2 (de) 6-(2-imidazolinylamino)chinolin-verbindungen als alpha-2-adrenoceptor-antagonisten
DE1908991C3 (enExample)
DE2925943A1 (de) 1-alkadien-2,4-yl-2-hydroxymethyl3,4,5-trihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE1908991B2 (de) Alpha, alpha-disubstituierte n- benzylimidazole und deren salze
EP1176144A1 (de) Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten
DE3028927C2 (de) Azoverbindungen enthaltendes pharmazeutisches Mittel
DE2716402A1 (de) 7-(2,3-dihydroxypropyl)-1,3-di-n- propylxanthin, verfahren zu seiner herstellung und diese verbindung enthaltende arzneimittel
DE3779842T2 (de) Antiallergisches mittel.
DE3618724C2 (de) N-[3-(Nitro)-chinol-4-yl]-carboxamidinamide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2403122A1 (de) Chemische verbindungen
DE1963317A1 (de) Chemische Verfahren und Produkte
EP0045911B1 (de) Neue Aminopropanol-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2322561A1 (de) Trisubstituierte imidazole
DE3650311T2 (de) Verwendung von Quinazolinen zur Herstellung eines Arzneimittels zur Behandlung und Vorbeugung von Arrhythmie.
DE2705817A1 (de) Neue anti-hypertonische zubereitungen mit gehalt an phenylhydrazinpropionsaeure und blutdrucksenkendem mittel
DE2508251C2 (de) Derivate des Indols, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel
DE2939914A1 (de) N-(1-methyl-2-pyrrolidinylmethyl)-2,3- dimethoxy-5-methylsulfamoylbenzamid, verfahren zu seiner herstellung und seine therapeutische verwendung
DE60311134T2 (de) Oromukosale formulierung und herstellungsverfahren dafür
DE2059620A1 (de) Neuartige Aminoaethansulfonsaeurederivate
DE3107599C2 (de) N-Cyan-N'-methyl-N"-{2-[(5-methylthio-imidazol-4-yl)-methylthio]-äthyl}-guanidin, Verfahren zu seiner Herstellung und diese Verbindung enthaltende Arzneimittel
DE2628642C2 (de) In 2-Stellung substituierte 1,3-Diaza-fünfringkohlenstoffverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
AT338781B (de) Verfahren zur herstellung neuer 1,3-benzodioxol-derivate und ihrer salze

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee